Chemotherapy : there is a shortage of treatment in Auxerre
Published the 09.07.2017 at 13h42 on
For several days, the hospital of Auxerre was facing a situation difficult to comprehend : the shortage of medicines. And more specifically carboplatin, a molecule used in treatment against cancers of the lung or ovaries, according to France Bleu Auxerre.
The regional radio reports the testimony of Jeanine, who is receiving chemotherapy for two months. Last Tuesday, she has had a bad surprise : “When the first pocket was empty, the nurse came to tell me that she would not be the second, because they were out of stock. I was told “go home”. I was shocked ! “Other molecules have been proposed for ill people, but not all of them can not stand them.
Results : patients in chemotherapy at the hospital of Auxerre are obliged to go up-way (approximately 80 kilometers), to track their treatment, reports France Bleu Auxerre.
Back to normal at the end of July
Manufactured in Asia, the carboplatin is in rupture with the French distributors for the past several days. A result, hospitals are no longer supplied. “This is the first time that a shortage so important and if long happens to us without anyone we can not supply,” explains the micro of France Bleu Auxerre dr. Frederick Martin, pharmacist at centre hospitalier Auxerre. The situation should return to normal at the end of July.
A situation reminiscent in any case, the one that lives in England, where to an antibiotic, piperacillin-tazobactam, administered intravenously in intensive care, suffering from a shortage. This medicine is used to treat a wide variety of diseases, including cystic fibrosis, pneumonia, urinary tract infection, or neutropenia, a hematological disorder that occurs particularly in patients treated with chemotherapy.
Just as carboplatin, piperacillin-tazobactam is manufactured in China. The shortage of the latter would be due to the explosion of the plant that produces the raw materials needed to manufacture the drug.